Brain Injury

·MeSH: Brain Injuries

24 drugs in development·14 companies·1 clinical trial

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
NT 201	Revance Therapeutics, Inc. (RVNC)
Standard Care	UNITED THERAPEUTICS Corp (UTHR)

Phase 2(10)

Drug	Company
allopregnanolone	GH Research PLC (GHRS)
BoNT A	UNITED THERAPEUTICS Corp (UTHR)
BoNT A	Revance Therapeutics, Inc. (RVNC)
Cold Stored Platelets	UNITED THERAPEUTICS Corp (UTHR)
muse stem cell therapy	HWH International Inc. (HWH)
onp-002	ORAGENICS INC (OGEN)
oxycyte	TENAX THERAPEUTICS, INC. (TENX)
Sham	Valneva SE (VALN)
Tranexamic Acid	UNITED THERAPEUTICS Corp (UTHR)
Valproic Acid	UNITED THERAPEUTICS Corp (UTHR)

Phase 1(3)

Drug	Company
Angiotensin	UNITED THERAPEUTICS Corp (UTHR)
hutrukin	XBiotech Inc. (XBIT)
Zoledronic acid	UNITED THERAPEUTICS Corp (UTHR)

Preclinical(8)

Drug	Company
ALPHA-1062 intranasal (ALPHA-1062IN)	Alpha Cognition Inc. (ACOG)
alpha-1062 sublingual	Alpha Cognition Inc. (ACOG)
ANVS405	Annovis Bio, Inc. (ANVS)
feldetrex	PREMIER BIOMEDICAL INC (BIEI)
ht-tbi	Hoth Therapeutics, Inc. (HOTH)
kls-13019	NEUROPATHIX, INC. (TYGS)
kls-13023	NEUROPATHIX, INC. (TYGS)
sequential-dialysis technique	PREMIER BIOMEDICAL INC (BIEI)

Phase 4(1)

Drug	Company
Sufentanyl	COGNITION THERAPEUTICS INC (CGTX)

BioSniper tracks 24 drugs in development for Brain Injury across 14 companies.

There are 1 clinical trial targeting Brain Injury tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.